Press release
Jul 24, 2015

Sosei Announces Choice of Listing Markets

Tokyo, Japan – 24 July 2015: Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565) announced today that based on Article 316 of the Securities Listing Regulations, which relates to the choice of listing markets for a company that has remained on the Mothers market for 10 years since listing, it has decided to remain listed on Mothers and will apply to change its listing market to Section 1 of the Tokyo Stock Exchange during the fiscal year ending March 2017.

Sosei was founded in 1990 and listed on Tokyo Stock Exchange Mothers in July 2004. Sosei then aimed to expand its business by acquiring other biopharmaceutical companies, and has evolved as a pioneer in the domestic biopharmaceutical industry. In the future, based on the vision dating back to its inception—“to help patients worldwide by becoming a leading global biopharmaceutical company originated from Japan”—the company will strive for further development by aiming for the well recognised and highly trusted Tokyo Stock Exchange Section 1.